Early limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) Randomized Trial

BACKGROUND: Interim results from the CHER trial showed that early antiretroviral therapy (ART) was life-saving for HIV-infected infants. Given limited options and potential for toxicity with life-long ART, CHER compared early limited ART with deferred ART. METHODS: CHER was an open 3-arm trial in HI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cotton, Mark F, Violari, Avy, Otwombe, Kennedy, Panchia, Ravindre, Dobbels, Els, Rabie, Helena, Josipovic, Deirdre, Liberty, Afaff, Lazarus, Erica, Innes, Steve, van Rensburg, Anita Janse, Pelser, Wilma, Truter, Handre, Madhi, Shabir A, Handelsman, Edward, Jean-Philippe, Patrick, McIntyre, James A, Gibb, Diana M, Babiker, Abdel G
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104982/
https://ncbi.nlm.nih.gov/pubmed/24209829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)61409-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares